
Summary
The popularity of GLP-1 medications, such as Ozempic and Wagovi, continues to rise in Canada, with many individuals turning to these drugs for weight management. Dr. Sean Wharton, an internal medicine physician and weight management specialist, highlights that while these medications are becoming a common choice, they should not replace fundamental health practices like proper nutrition and exercise. He emphasizes the importance of maintaining a holistic approach to health, even with the availability of these pharmaceutical options.
Dr. Wharton also addresses the trend of individuals using these medications in a non-prescriptive manner, such as micro-dosing or cycling on and off the drugs for short-term weight loss goals. He cautions against this practice, noting that obesity is a chronic disease requiring long-term management. The physician expresses concern over the potential for these medications to be misused, particularly as they become more accessible through online channels, which could lead to a lack of proper medical oversight.
Regarding the long-term effects of discontinuing GLP-1 medications, Dr. Wharton explains that while many patients may regain weight after stopping the drugs, some do not. He suggests that further research is needed to understand the factors influencing weight regain and the potential benefits of lifestyle modifications during and after medication use. Ultimately, he advocates for consulting with healthcare professionals to ensure safe and effective weight management strategies.
Show Notes
Long-term medication or modern crash diet?
Learn more about your ad choices. Visit megaphone.fm/adchoices
More from Shaye Ganam
'Capital Conversations' with Melissa Caouette, Shannon Greer and Colin Aitchison
The trade war will hurt the U.S. more than us
Why won't Canada build more diesel refineries?
Experience the history, beauty and irresistible charm of Greece on this 11-day journey with Shaye and Network Travel. More information available here: https://networktravel.ca/greece-with-shaye-2027